For 40 years scientists have hotly debated the questions of how chloroquine
kills malarial parasites and how resistance to this once first-line antima
larial drug has evolved. While an end to these debates is not in sight, as
a result of the complexity of the subject, new findings have come forward t
hat give the discussion a new direction. In this paper we will summarize cu
rrent knowledge on chloroquine's antimalarial mode of action and the genesi
s of the resistant phenotype in the human malarial parasite Plasmodium falc
iparum, with special emphasis on the most recent developments in this field
. Curr Opin Infect Dis 13:653-658. (C) 2000 Lippincott Williams & Wilkins.